AMBALAL SARABHAI ENTERPRISES
Back to Cashflow Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-18 Cr | ₹8.89 Cr | ₹5.72 Cr | ₹11 Cr | ₹-2.30 Cr |
What is the latest Cash Flow from Operating Activities ratio of AMBALAL SARABHAI ENTERPRISES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-18 Cr |
| Mar2024 | ₹8.89 Cr |
| Mar2023 | ₹5.72 Cr |
| Mar2022 | ₹11 Cr |
| Mar2021 | ₹-2.30 Cr |
How is Cash Flow from Operating Activities of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-18 Cr | Negative | |
| Mar2024 | ₹8.89 Cr | 55.23 | |
| Mar2023 | ₹5.72 Cr | -50.10 | |
| Mar2022 | ₹11 Cr | Positive | |
| Mar2021 | ₹-2.30 Cr | - | |
Compare Cash Flow from Operating Activities of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹202.8 Cr | -5.5% | 1.5% | -45.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,753.0 Cr | 1.5% | 5.5% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,032.0 Cr | 2.3% | 3.6% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,426.0 Cr | -0.5% | 5.3% | 40.2% | Stock Analytics | |
| CIPLA | ₹108,360.0 Cr | -1.1% | -2.2% | -8.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,859.0 Cr | 0.9% | 5.2% | 7% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | -5.5% |
1.5% |
-45.1% |
| SENSEX | 0.2% |
1.1% |
8.8% |
You may also like the below Video Courses